Utah OTC Firm Warned for Oversight and Sterility Problems

Drug Industry Daily
A A
The FDA hit OTC drugmaker Results RNA with a second warning letter in just over a year, this time for GMP violations at its Orem, Utah facility.

To View This Article:

Login

Subscribe To Drug Industry Daily